NASDAQ:ASTH

Astrana Health (ASTH) Stock Price, News & Analysis

Astrana Health logo
$28.90 +0.22 (+0.77%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$28.86 -0.04 (-0.16%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Astrana Health Stock (NASDAQ:ASTH)

Advanced

Key Stats

Today's Range
$28.33
▼
$29.75
50-Day Range
$28.66
▼
$39.67
52-Week Range
$18.08
▼
$51.60
Volume
440,985 shs
Average Volume
401,304 shs
Market Capitalization
$1.61 billion
P/E Ratio
27.01
Dividend Yield
N/A
Price Target
$50.38
Consensus Rating
Moderate Buy

Company Overview

Astrana Health, Inc. is a physician-centric healthcare company that coordinates and delivers care through a network of primary care physicians, specialists and other providers. Its services include primary and specialty care, care coordination, hospital-based care and technology-enabled population health management.

The company works with health plans and provider groups under value-based care arrangements, which emphasize coordinating care and managing patients’ health needs across different settings. Astrana has roots in California and has expanded its operations beyond the state.

Previously known as Apollo Medical Holdings, the company adopted the Astrana Health name in 2024. Brandon Sim serves as its chief executive officer.

AI Generated. May Contain Errors.

Astrana Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
66th Percentile Overall Score

ASTH MarketRank™: 
3.28265134529 of 5 stars

Astrana Health scored higher than 66% of companies evaluated by MarketBeat, and ranked 164th out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Astrana Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.70, and is based on no strong buy ratings, 8 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Astrana Health has a consensus price target of $50.38, representing about 74.3% upside from its current price of $28.90.

  • Amount of Analyst Coverage

    Astrana Health has only been the subject of 4 research reports in the past 90 days.

  • Read more about Astrana Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Astrana Health are expected to grow by 45.08% in the coming year, from $1.22 to $1.77 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Astrana Health is 27.01, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.18.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Astrana Health is 27.01, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.56.

  • Price to Book Value per Share Ratio

    Astrana Health has a P/B Ratio of 1.86. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    6.74% of the float of Astrana Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Astrana Health has a short interest ratio ("days to cover") of 12.28, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Astrana Health has recently decreased by 0.51%, indicating that investor sentiment is improving.
  • Dividend Yield

    Astrana Health does not currently pay a dividend.

  • Dividend Growth

    Astrana Health does not have a long track record of dividend growth.

  • News Sentiment

    Astrana Health has a news sentiment score of -0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Astrana Health this week, compared to 4 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Astrana Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    20.30% of the stock of Astrana Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Astrana Health's insider trading history.
Receive ASTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Astrana Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ASTH Stock News Headlines

Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
See More Headlines

ASTH Stock Analysis - Frequently Asked Questions

Astrana Health's stock was trading at $24.81 at the beginning of 2026. Since then, ASTH stock has increased by 16.5% and is now trading at $28.90.

Astrana Health, Inc. (NASDAQ:ASTH) posted its quarterly earnings data on Thursday, November, 5th. The company reported $0.71 earnings per share for the quarter, topping analysts' consensus estimates of $0.46 by $0.25. Astrana Health's quarterly revenue was up 7.1% on a year-over-year basis.
Read the conference call transcript
.

Astrana Health's top institutional investors include State Street Corp (3.17%), Goldman Sachs Group Inc. (0.86%), SteelPeak Wealth LLC (0.78%) and Royce & Associates LP (0.75%).

Shares of ASTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/05/2026
Today
11/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:ASTH
Previous Symbol
NASDAQ:ASTH
CIK
1083446
Employees
3,000
Year Founded
1985

Price Target and Rating

High Price Target
$65.00
Low Price Target
$37.00
Potential Upside/Downside
+74.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.70
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.07
Trailing P/E Ratio
27.01
Forward P/E Ratio
16.33
P/E Growth
N/A
Net Income
$22.49 million
Net Margins
1.36%
Pretax Margin
2.21%
Return on Equity
11.57%
Return on Assets
4.17%

Debt

Debt-to-Equity Ratio
1.00
Current Ratio
1.25
Quick Ratio
1.25

Sales & Book Value

Annual Sales
$3.18 billion
Price / Sales
0.51
Cash Flow
$2.81 per share
Price / Cash Flow
10.27
Book Value
$15.56 per share
Price / Book
1.86

Miscellaneous

Outstanding Shares
55,800,000
Free Float
44,473,000
Market Cap
$1.61 billion
Optionable
Optionable
Beta
1.18

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NASDAQ:ASTH) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners